Global mRNA Raw Enzyme Market Growth (Status and Outlook) 2023-2029

Global mRNA Raw Enzyme Market Growth (Status and Outlook) 2023-2029

The global mRNA Raw Enzyme market size is projected to grow from US$ 3574.8 million in 2022 to US$ 1989.8 million in 2029; it is expected to grow at a CAGR of -8.0% from 2023 to 2029.

The key global manufacturers of mRNA raw enzymes are Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, and others. The top two manufacturers together account for 50% of the market share, with the largest manufacturer being Thermo Fisher, accounting for 27% of the market share. The global origin is mainly distributed in North America, Europe, China, Japan, etc. From the consumer level, North America holds the largest market share, accounting for 40%. In terms of its product category, capping enzymes hold the largest market share with 25%, followed by 2'-O-methyltransferase and inorganic pyrophosphatase with 20% and 13%, respectively. In terms of applications, biopharmaceutical companies are the top application area with 80% of the market share, while the rest of the applications are in academic and research institutions.

mRNA raw enzyme is the key raw material in the production of mRNA vaccine and drugs. The research, development and production of mRNA drugs involve restriction endonuclease, RNA polymerase, capping enzyme, Poly (A) polymerase and other enzyme materials.

In this report, mRNA Raw Enzyme includes Restriction Enzyme, RNA Polymerase, Capping Enzyme, Inorganic Pyrophosphatase, RNase Inhibitor, 2'-O-Methyltransferase, Poly(A) Polymerase and DNase I.


LPI (LP Information)' newest research report, the “mRNA Raw Enzyme Industry Forecast” looks at past sales and reviews total world mRNA Raw Enzyme sales in 2022, providing a comprehensive analysis by region and market sector of projected mRNA Raw Enzyme sales for 2023 through 2029. With mRNA Raw Enzyme sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Raw Enzyme industry.

This Insight Report provides a comprehensive analysis of the global mRNA Raw Enzyme landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Raw Enzyme portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Raw Enzyme market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Raw Enzyme and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Raw Enzyme.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Raw Enzyme market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Restriction Enzyme
RNA Polymerase
Capping Enzyme
Inorganic Pyrophosphatase
RNase Inhibitor
2'-O-Methyltransferase
Poly(A) Polymerase
DNase I
Others

Segmentation by application
Biopharmaceutical Companies
Academic and Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio

Please note: The report will take approximately 2 business days to prepare and deliver.